International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 4 , Pages 1054-1060 , 15 March 2010

Health-Related Quality of Life up to Six Years After 125I Brachytherapy for Early-Stage Prostate Cancer

  • Ellen M.A. Roeloffzen, M.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • Corresponding Author InformationReprint requests to: Ellen Roeloffzen, M.D., Department of Radiation Oncology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX The Netherlands. Tel: (+31) 88-755-8800; Fax: (+31) 88-755-5850
    • ,
  • Irene M. Lips, M.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Marion P.R. van Gellekom, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Joep van Roermund, M.D.

      Affiliations

    • Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Steven J. Frank, M.D.

      Affiliations

    • Department of Radiation Oncology, M. D. Anderson Medical Center, Houston, TX
    • ,
  • Jan J. Battermann, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Marco van Vulpen, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Received 10 February 2009 ,Revised 11 March 2009 ,Accepted 16 March 2009.

  • Image Result

    Urinary symptom scores (mean and 95% confidence intervals (CIs)) of the European Organization for Research and Treatment of Cancer prostate cancer module (EORTC QLQ-PR25) up to 6 years after 125I pros

    Urinary symptom scores (mean and 95% confidence intervals (CIs)) of the European Organization for Research and Treatment of Cancer prostate cancer module (EORTC QLQ-PR25) up to 6 years after 125I prostate brachytherapy. Higher score represents more symptoms or more problems.

  • Image Result
    Bowel symptom scores (mean and 95% confidence intervals (CIs)) of the European Organization for Research and Treatment of Cancer prostate cancer module (EORTC QLQ-PR25) up to 6 years after 125I prosta

    Bowel symptom scores (mean and 95% confidence intervals (CIs)) of the European Organization for Research and Treatment of Cancer prostate cancer module (EORTC QLQ-PR25) up to 6 years after 125I prostate brachytherapy. Greater score represents more symptoms or more problems.

  • Image Result
    Emotional functioning scores (mean and 95% confidence intervals (CIs)) of the European Organization for Research and Treatment of Cancer core questionnaire (EORTC QLQ-C30) up to 6 years after 125I pro

    Emotional functioning scores (mean and 95% confidence intervals (CIs)) of the European Organization for Research and Treatment of Cancer core questionnaire (EORTC QLQ-C30) up to 6 years after 125I prostate brachytherapy. Higher score represents greater level of emotional functioning.

  • Image Result
    Sexual activity scores (mean and 95% confidence intervals (CIs)) of the European Organization for Research and Treatment of Cancer prostate cancer module (EORTC QLQ-PR25) up to 6 years after 125I pros

    Sexual activity scores (mean and 95% confidence intervals (CIs)) of the European Organization for Research and Treatment of Cancer prostate cancer module (EORTC QLQ-PR25) up to 6 years after 125I prostate brachytherapy. A higher score represents a higher level of sexual activity.

 Note—An online CME test for this article can be taken at http://asro.astro.org under Continuing Education.

 Conflict of interest: none.

PII: S0360-3016(09)00509-4

doi: 10.1016/j.ijrobp.2009.03.045

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 4 , Pages 1054-1060 , 15 March 2010

Article Tools

* Image Usage & Resolution